XM does not provide services to residents of the United States of America.
P
P

Philips

Trade Ideas

Traders Sentiment

Technical Summary

Hourly

News

Philips And AWS Collaborate To Scale Digital Pathology In Cloud

BRIEF-Philips And AWS Collaborate To Scale Digital Pathology In Cloud March 12 (Reuters) - Koninklijke Philips NV PHG.AS : PHILIPS AND AWS AMZN.O COLLABORATE TO SCALE DIGITAL PATHOLOGY IN THE CLOUD, ENHANCING DIAGNOSTIC CAPABILITIES AND IMPROVING PRODUCTIVITY CLOUD OFFERING WILL HELP IMPROVE WORKFLOW INTEGRATION, ACCESS, AND RELIABILITY, DELIVERING
A
P

Exor takes 10% stake in data provider Clarivate, can rise to 17.5%

UPDATE 1-Exor takes 10% stake in data provider Clarivate, can rise to 17.5% Adds background in paragraphs 2 and 5-8 MILAN, March 4 (Reuters) - Italy's Agnelli family has a 10.1% stake in New York-listed information services provider Clarivate 16A.F through their investment arm Exor EXOR.AS , the two companies said on Monday, adding that Exor could increase its stake to up to 17.5%.
F
P
J

Philips Appoints Charlotte Hanneman As New CFO

BRIEF-Philips Appoints Charlotte Hanneman As New CFO Feb 28 (Reuters) - Koninklijke Philips NV PHG.AS : CHARLOTTE HANNEMAN TO SUCCEED ABHIJIT BHATTACHARYA AS PHILIPS’ CHIEF FINANCIAL OFFICER (CFO) APPOINT CHARLOTTE HANNEMAN AS MEMBER OF BOARD OF MANAGEMENT, FULFILLING ROLE OF CHIEF FINANCIAL OFFICER (CFO), EFFECTIVE OCTOBER 1, 2024 PROPOSAL WILL
P

Philips Launches New Azurion Neuro Biplane System

BRIEF-Philips Launches New Azurion Neuro Biplane System Feb 27 (Reuters) - Koninklijke Philips NV PHG.AS : PHILIPS LAUNCHES NEW AZURION NEURO BIPLANE SYSTEM AT #ECR2024 TO SPEED UP AND IMPROVE MINIMALLY INVASIVE DIAGNOSIS AND TREATMENT OF NEUROVASCULAR PATIENTS Source text for Eikon: ID:nGNX9CrS9c Further company coverage: PHG.AS
P

Rotech says patients likely impacted by hack at partner Philips' unit

UPDATE 1-Rotech says patients likely impacted by hack at partner Philips' unit Adds Philips' emailed response in paragraph 5 Feb 23 (Reuters) - U.S.-based medical devices provider Rotech Healthcare ROTK.O said on Friday it was reviewing a list of patients who may have been impacted due to a cybersecurity breach experienced by its partner Philips' PHG.AS Respironics unit.
P

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.